MoneyWorks4Me

Sun Pharmaceutical Industries board to consider unaudited financial result

28 Oct 2013 Evaluate

Sun Pharmaceutical Industries has informed that a meeting of the Board of Directors of the Company will be held on November 13, 2013, to consider and take on record the un-audited financial results of the Company for the second quarter/half year ended September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..